Faecalibacterium sp.

Information

Microbe Identification

Faecalibacterium sp.

Microbe id: PMDBM2021533
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Faecalibacterium sp. [1971605]
Taxonomy Genus: Faecalibacterium [216851]
Taxonomy Family: Oscillospiraceae [216572]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Faecalibacterium sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Faecalibacterium sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Faecalibacterium sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Faecalibacterium sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Faecalibacterium sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA648014🔗4.5281657758842716S
Hemangioma, Cavernous PRJNA629755🔗-4.55243895879158mNGS
Hypertension PRJNA509999🔗-4.26959944030467mNGS
Depression, Postpartum PRJNA637228🔗-5.0812550137961716S
Diabetes Mellitus, Type 2 PRJNA588353🔗-4.7004667773547616S
Diabetes Mellitus, Type 2 PRJDB9608🔗-4.6199175197553116S
Liver Cirrhosis, Alcoholic PRJNA690835🔗-4.1680305799461616S
Coronary Disease PRJNA818062🔗4.76652345672155mNGS
Diarrhea PRJEB14038🔗-4.85337569543113mNGS
Diarrhea PRJNA317326🔗-3.9758467467520216S
Colorectal Neoplasms PRJNA284542🔗-5.2400844728343516S
Colorectal Neoplasms PRJEB53891🔗-5.03953483337609mNGS
Colorectal Neoplasms PRJNA888860🔗-4.82223502015388mNGS
Colorectal Neoplasms PRJEB46665🔗-4.72666499596816S
Colorectal Neoplasms PRJNA961076🔗-4.71473978339477mNGS
Colorectal Neoplasms PRJEB70916🔗-4.70652705196988mNGS
Colorectal Neoplasms PRJNA763023🔗-4.50261337635598mNGS
Colorectal Neoplasms PRJNA698923🔗-4.5025567537606916S
Colorectal Neoplasms PRJNA1138893🔗-4.1881808850814mNGS
Colorectal Neoplasms PRJNA936589🔗4.53965568233742mNGS
Colorectal Neoplasms PRJNA1050885🔗4.67144122647357mNGS
Lupus Erythematosus, Systemic PRJEB39044🔗-5.1203051446621516S
Lupus Erythematosus, Systemic PRJEB52971🔗-4.4123557081748616S
Diabetes Mellitus, Type 1 PRJNA893406🔗-4.17259849970671mNGS
Hepatitis, Viral, Human PRJNA540738🔗-4.014585546307216S
Hepatitis, Autoimmune PRJNA556801🔗4.912126133657416S
Parkinson Disease PRJEB53403🔗-4.56250095908125mNGS
Colitis, Ulcerative PRJEB42155🔗-4.8069500546729mNGS
Colitis, Ulcerative PRJNA429990🔗-4.71936079821451mNGS
Colitis, Ulcerative PRJNA804422🔗-4.6740315271032416S
Colitis, Ulcerative PRJNA820056🔗-3.9872395628002816S
Campylobacter Infections PRJNA660443🔗-4.36156855076808mNGS
Spinal Cord Injuries PRJNA669472🔗-5.1531751608183616S
Carcinoma, Hepatocellular PRJNA872871🔗-4.2216564202464416S
Celiac Disease PRJNA890948🔗-4.2888249019155116S
Narcolepsy PRJEB38491🔗-4.4257328689070716S
Caliciviridae Infections PRJNA788674🔗-4.7742915535516416S
Hepatolenticular Degeneration PRJNA1038771🔗-4.6020347818326816S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-4.5674533202435116S
Non-alcoholic Fatty Liver Disease PRJNA540738🔗-3.8542594958568916S
Prostatic Neoplasms PRJDB10718🔗-4.3083843620564316S
Crohn Disease PRJDB6133🔗-5.5197849702813516S
Crohn Disease PRJNA793776🔗-5.00847997345391mNGS
Crohn Disease PRJEB42155🔗-4.99808244801403mNGS
Crohn Disease PRJNA429990🔗-4.74537891858893mNGS
Crohn Disease PRJNA1156939🔗-4.5571114338311716S
Crohn Disease PRJNA813736🔗-4.52193194977178mNGS
Crohn Disease PRJNA398089🔗-4.40066973102163mNGS
Crohn Disease PRJNA917086🔗-4.3990117323264416S
Crohn Disease PRJNA993675🔗-4.32916827258778mNGS
Psoriasis PRJNA938297🔗-4.44640628703862mNGS
Psoriasis PRJNA574485🔗5.0417018347405416S
Cholestasis PRJNA540738🔗-4.0224171770152216S
Moyamoya Disease PRJNA917033🔗-4.087558814959216S
Multiple System Atrophy PRJNA386851🔗-4.9551725764952516S
Diabetic Retinopathy PRJNA646010🔗-4.7928567022456816S
Diabetic Retinopathy PRJNA857030🔗-3.9347752370942216S
Arthritis, Rheumatoid PRJNA786110🔗-5.1319465263145816S
Arthritis, Rheumatoid PRJNA896336🔗4.735180023071mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗-4.5812069949124mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗-4.27434613332599mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-4.03129818006841mNGS
Autoimmune Diseases of the Nervous System PRJNA586763🔗5.3478170640681716S
Nephrotic Syndrome PRJNA800189🔗-4.8072622399335216S
Growth Hormone-Secreting Pituitary Adenoma PRJNA743650🔗3.6719360336551216S
Flatulence PRJNA206071🔗-4.4210534560557216S
Anorexia Nervosa PRJEB38930🔗-4.2069516979380316S
Hepatitis C PRJNA1070593🔗-4.4533728666514916S
Neuroblastoma PRJEB63351🔗-4.68097855646433mNGS
Neuroblastoma PRJNA716780🔗-4.57076885308441mNGS
Hematologic Neoplasms PRJNA777832🔗-4.873830722935616S
Irritable Bowel Syndrome PRJEB37924🔗-4.09395994248136mNGS
IgA Deficiency PRJNA967340🔗4.5904479252950916S
Depressive Disorder, Major PRJNA591924🔗-4.892344497453216S
Depressive Disorder, Major PRJNA762199🔗-4.63201676184593mNGS
Clostridium Infections PRJNA648321🔗3.88392719087505mNGS
Cholelithiasis PRJNA999028🔗-4.90344109604679mNGS
Atrial Fibrillation PRJNA728204🔗4.522399330970516S
Cystic Fibrosis PRJNA314903🔗-4.59597192234574mNGS
Anti-N-Methyl-D-Aspartate Receptor Encephalitis PRJNA764676🔗-4.4763864030392816S
Hypercholesterolemia PRJNA842179🔗-4.4175877447504516S
HIV Infections PRJDB11949🔗-4.8584505213543216S
HIV Infections PRJNA810567🔗-4.5282952895112216S
Autism Spectrum Disorder PRJNA686821🔗-4.51831343581468mNGS
Autism Spectrum Disorder PRJNA746094🔗-4.2224919204390916S
Autism Spectrum Disorder PRJNA1037036🔗3.97817255009279mNGS
Inflammatory Bowel Diseases PRJNA1028828🔗-4.3610449783332716S
Hand, Foot and Mouth Disease PRJNA843173🔗-4.7064613845346216S
Biliary Atresia PRJNA730640🔗-5.10692105865537mNGS
Renal Insufficiency, Chronic PRJNA949558🔗-4.9420765416830416S
Renal Insufficiency, Chronic PRJEB34855🔗-4.3837892618339116S
Renal Insufficiency, Chronic PRJEB65297🔗-4.05541133861156mNGS
Breast Neoplasms PRJNA383849🔗-4.3083595959654616S
COVID-19 PRJNA678695🔗-4.6532709696626416S
COVID-19 PRJNA624223🔗-4.4428263312504mNGS
COVID-19 PRJNA689961🔗-4.37442878139378mNGS
COVID-19 PRJDB13214🔗-4.00126681677091mNGS
COVID-19 PRJNA769052🔗4.7661021907482116S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Faecalibacterium sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Faecalibacterium sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Faecalibacterium sp.

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Faecalibacterium sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Faecalibacterium sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Faecalibacterium sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Faecalibacterium sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Faecalibacterium sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Faecalibacterium sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Faecalibacterium sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Faecalibacterium sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?